Lorraine Spector

Array ( [id] => 5828045 [patent_doc_number] => 20060063203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Vascular endothelial cell growth factor variants and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/204554 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20319 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063203.pdf [firstpage_image] =>[orig_patent_app_number] => 11204554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710958 [patent_doc_number] => 20060052303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Use of thyrotropin for regeneration of bone' [patent_app_type] => utility [patent_app_number] => 11/190465 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9829 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052303.pdf [firstpage_image] =>[orig_patent_app_number] => 11190465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793988 [patent_doc_number] => 20060014669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Method for treating cancer and increasing hematocrit levels' [patent_app_type] => utility [patent_app_number] => 11/153086 [patent_app_country] => US [patent_app_date] => 2005-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17025 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014669.pdf [firstpage_image] =>[orig_patent_app_number] => 11153086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7068988 [patent_doc_number] => 20050244371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Method and system to remove cytokine inhibitor in patients' [patent_app_type] => utility [patent_app_number] => 11/153524 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6538 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244371.pdf [firstpage_image] =>[orig_patent_app_number] => 11153524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926757 [patent_doc_number] => 20050240014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Connective tissue growth factor homologs' [patent_app_type] => utility [patent_app_number] => 11/149564 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 27341 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20050240014.pdf [firstpage_image] =>[orig_patent_app_number] => 11149564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977920 [patent_doc_number] => 20050287638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 11/128059 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 51081 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287638.pdf [firstpage_image] =>[orig_patent_app_number] => 11128059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931198 [patent_doc_number] => 20050282233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Multivalent antibody materials and methods for VEGF/PDGF family of growth factors' [patent_app_type] => utility [patent_app_number] => 11/075400 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 41702 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282233.pdf [firstpage_image] =>[orig_patent_app_number] => 11075400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826641 [patent_doc_number] => 07402304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'Methods of using G-CSF analog compositions' [patent_app_type] => utility [patent_app_number] => 11/047064 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21008 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402304.pdf [firstpage_image] =>[orig_patent_app_number] => 11047064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050716 [patent_doc_number] => 20050186603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Novel human thrombopoietin mutein' [patent_app_type] => utility [patent_app_number] => 11/043387 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9594 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186603.pdf [firstpage_image] =>[orig_patent_app_number] => 11043387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663580 [patent_doc_number] => 20080254487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Connective Tissue Growth Factor Signaling' [patent_app_type] => utility [patent_app_number] => 10/586318 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12434 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254487.pdf [firstpage_image] =>[orig_patent_app_number] => 10586318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040357 [patent_doc_number] => 20050159358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Growth factor homolog zvegf3' [patent_app_type] => utility [patent_app_number] => 11/021088 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 42407 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159358.pdf [firstpage_image] =>[orig_patent_app_number] => 11021088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250001 [patent_doc_number] => 20050142107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Use of IL-6-type cytokines for maturation of oocytes' [patent_app_type] => utility [patent_app_number] => 10/998080 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7662 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142107.pdf [firstpage_image] =>[orig_patent_app_number] => 10998080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334145 [patent_doc_number] => 07507556 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Nucleic acids encoding rat hyaluronan receptor for endocytosis' [patent_app_type] => utility [patent_app_number] => 10/990844 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 29267 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507556.pdf [firstpage_image] =>[orig_patent_app_number] => 10990844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7039306 [patent_doc_number] => 20050158740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Variants of human glycoprotein hormone alpha chain: compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/984379 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33231 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158740.pdf [firstpage_image] =>[orig_patent_app_number] => 10984379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5153905 [patent_doc_number] => 20070036788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Use of a compound for reducing the biological effectiveness of il-6' [patent_app_type] => utility [patent_app_number] => 10/573049 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4049 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036788.pdf [firstpage_image] =>[orig_patent_app_number] => 10573049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905594 [patent_doc_number] => 20050100989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'FSH glycosylation mutant' [patent_app_type] => utility [patent_app_number] => 10/934707 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9093 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100989.pdf [firstpage_image] =>[orig_patent_app_number] => 10934707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330669 [patent_doc_number] => 20090111146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Antibody Drug' [patent_app_type] => utility [patent_app_number] => 10/570143 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 6343 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111146.pdf [firstpage_image] =>[orig_patent_app_number] => 10570143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088994 [patent_doc_number] => 20050009107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'G-protein parathyroid hormone receptor HLTDG74' [patent_app_type] => utility [patent_app_number] => 10/921218 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12584 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009107.pdf [firstpage_image] =>[orig_patent_app_number] => 10921218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061126 [patent_doc_number] => 20050003487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Chordin dorsalizing and hemoglobin inducing polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 10/901400 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 64660 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003487.pdf [firstpage_image] =>[orig_patent_app_number] => 10901400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 103125 [patent_doc_number] => 07723488 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Monoclonal antibodies to secreted and transmembrane polypeptides' [patent_app_type] => utility [patent_app_number] => 10/897359 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 237 [patent_figures_cnt] => 237 [patent_no_of_words] => 186172 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723488.pdf [firstpage_image] =>[orig_patent_app_number] => 10897359 [rel_patent_id] =>[rel_patent_doc_number] =>)